FiercePharma4h
While Novo and Lilly's market value declined in Q3, BMS, Gilead and Sanofi surged: GlobalData
Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...
FiercePharma22h
Moderna disappoints in RSV debut, squares up with Pfizer in COVID-19 vaccine sales
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
FiercePharma18h
Sparked by FDA expansion, Sarepta's Elevidys takes another leap in sales
An FDA expansion of Sarepta Therapeutics’ Duchenne muscular dystrophy (DMD) Elevidys has sparked a new surge in sales for the ...
FiercePharma22h
Gilead's CAR-T sales stagnate as Trodelvy takes another impairment hit
Despite a mission to become a dominant cancer drug player, Gilead Sciences has as of late been locked in on its ...
FiercePharma22h
Biologics CDMO Avid Bioservices to go private with $1.1B sale to Ampersand, GHO Capital
Just days after laying out $90 million to acquire Nektar Therapeutics’ Alabama manufacturing plant, Ampersand Capital ...
FiercePharma23h
More turbulence at Aurinia as autoimmune drugmaker lays off 45% of workforce
After an activist investor revolted against the leadership team at Aurinia Pharmaceuticals, the CEO in question is resorting ...
FiercePharma23h
AGC Biologics aims to become 'safe harbor' for manufacturing clients as new CEO takes the reins
Emerging from the rough waters of the CDMO industry with a new chief executive at the helm, AGC Biologics is on a mission to reinvent itself as a manufacturing partner defined by friendliness and e | ...